| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $17.4M | -4.7% |
| Cost of Revenue | $1.1M | -11.1% |
| R&D Expense | $7.8M | -15.0% |
| SG&A Expense | $6.4M | -2.8% |
| Operating Income | -$5.5M | +35.1% |
| Pre-tax Income | -$4.4M | +39.7% |
| Income Tax | $53K | -10.2% |
| Net Income | -$4.4M | +39.4% |
| EPS (Basic) | -$0.21 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $13.0M | +29.7% |
| Accounts Receivable | $2.9M | +19.1% |
| Current Assets | $33.0M | -7.9% |
| Total Assets | $42.6M | -7.9% |
| Current Liabilities | $7.9M | +4.2% |
| Stockholders' Equity | $30.9M | -9.9% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$3.2M | -273.4% |
| Capital Expenditures | $45K | +181.3% |
| Investing Cash Flow | $6.3M | +300.1% |
| Financing Cash Flow | -$159K | +62.7% |
| Free Cash Flow | -$3.2M | -277.4% |
| +40.0% |
| EPS (Diluted) | -$0.21 | +40.0% |